Literature DB >> 15828185

Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals.

L R Fare, P Actor, C Sachs, L Phillips, M Joloza, J F Pauls, J A Weisbach.   

Abstract

Six cephalosporin antibiotics were administered subcutaneously to mice at a level of 20 mg/kg. The serum levels of each were determined at five time intervals ranging from 5 to 120 min after dosing. Urinary recovery and the presence of active metabolites in mouse urine were determined. The peak serum levels and serum half-lives in mice were found to be positively correlated with the mean effective dose values obtained after lethal challenge with Escherichia coli. The administration of cefazolin and cephanone resulted in the highest serum level and the best protection. Good protection was obtained with cephaloridine despite somewhat lower serum levels. The cephalosporins with the acetoxy side chain (cephalothin, cephapirin, and cephacetrile) showed lower serum levels and the poorest protection. Cefazolin, cephaloridine, and cephalothin serum levels were also determined in dogs, squirrel monkeys, and rabbits. A mixed response was obtained in these species, with cefazolin peak serum levels being highest in rabbits and cephaloridine peak highest in dogs.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15828185      PMCID: PMC444620          DOI: 10.1128/AAC.6.2.150

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Cephapirin: pharmacology in normal human volunteers.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  J Clin Pharmacol New Drugs       Date:  1972 Feb-Mar

2.  Pharmacokinetics of cefazolin compared with four other cephalosporins.

Authors:  W M Kirby; C Regamey
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

3.  Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency.

Authors:  W A Craig; P G Welling; T C Jackson; C M Kunin
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Laboratory studies with a new cephalosporanic acid derivative.

Authors:  D R Chisholm; F Leitner; M Misiek; G E Wright; K E Price
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

5.  CIBA 36278-Ba" chemotherapy and toxicology in laboratory animals.

Authors:  F Kradolfer; W Sackmann; O Zak; H Brunner; R Hess; E A Konopka; J Gelzer
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects.

Authors:  R S Griffith; H R Black
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

7.  Antimicrobial studies in vitro with CIBA 36278-Ba, a new cephalosporin derivative.

Authors:  F Knüsel; E A Konopka; J Gelzer; A Rosselet
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

8.  Toxicity, distribution, and excretion of cephaloridine in laboratory animals.

Authors:  J S Welles; W R Gibson; P N Harris; P M Small; R C Anderson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Evaluation of a new cephalosporin antibiotic, cephapirin.

Authors:  P Wiesner; R MacGregor; D Bear; S Berman; K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

View more
  4 in total

1.  Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.

Authors:  P Actor; D H Pitkin; G Lucyszyn; J A Weisbach; J L Bran
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

Review 2.  Microbiological investigation of cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.

Authors:  T Yoshida; S Matsuura; M Mayama; Y Kameda; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  Antibiotic concentration in human wound fluid after intravenous administration.

Authors:  D H Bagley; J Mac Lowry; R M Beazley; C Gorschboth; A S Ketcham
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.